As of Wednesday close, Tenet Healthcare Corporation’s (NYSE:THC) stock was up $2.13, moving up 4.08 percent to $54.28. The average number of shares traded per day over the past five days has been 1,738,000 shares. 1 time new highs have been achieved over the past 5 days, with a $0.88 gain in that time frame. In the last twenty days, the average volume was 1,472,415, while in the previous 50 days, it was 1,608,544.
Since last month, THC stock retreated -15.83%. Shares of the company fell to $50.37 on 06/16/22, the lowest level in the past month. A 52-week high of $92.65 was reached on 03/29/22 after having rallying from a 52-week low of $50.37. Since the beginning of this year, THC’s stock price has dropped by -33.55% or -$27.41, and marked a new high 9 times. However, the stock has declined by -41.41% since its 52-week high.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Tenet Healthcare Corporation (THC) last reported insider trading activity 106 days ago on Mar 09. MARK RICHARD J, the Director of the company, disposed of 6,000 shares for $90.47 on Mar 09. It resulted in a $542,820 divestment by the insider. Rittenmeyer Ronald A sold 190,149 shares at an average price of $90.56 on Mar 03. The insider now owns 336,218 shares following the transaction. On Mar 02, Executive Chairman Rittenmeyer Ronald A sold 59,851 shares at $90.12 apiece. The transaction was valued at $5,393,772.
Right now, Tenet Healthcare Corporation (THC) has a P/E ratio of about 6.20. The stock’s beta is 2.35. Besides these, the trailing price-to-sales (P/S) ratio of 0.30, the price-to-book (PB) ratio of 5.53, and the price-to-cash flow ratio of 10.13 may also be considered.
In the three months ended March 30, Tenet Healthcare Corporation’s quick ratio stood at 1.20, while its current ratio was 1.30, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending March 30 was 13.94, and the total debt-to-equity ratio was 14.06. On the profitability front, the trailing twelve-month gross margin is 83.00% percent. In the year ended March 30, operating margins totaled 14.90%. Based on annual data, THC earned $7.28 billion in gross profit and brought in $19.48 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 14.30%. Return on equity (ROE) for the past 12 months was 124.80%.
In Tenet Healthcare Corporation’s quarter-end financial report for March 30, it reported total debt of $14.72 billion. According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. THC’s revenue fell -0.76% to $4.86 billion during the quarter, while net income inched up to $4.75 billion. While analysts expected Tenet Healthcare Corporation to report $1.04 quarterly earnings, the actual figure was $1.93 per share, beating the consensus estimate by 85.60%. During the quarter, the company generated $905.0 million in EBITDA. The liabilities of Tenet Healthcare Corporation were 24.59 billion at the end of its most recent quarter ended March 30, and its total debt was $14.85 billion. The value of shareholders’ equity is $107.72 million.
This quick technical analysis looks at Tenet Healthcare Corporation’s (THC) price momentum. With a historical volatility rate of 60.80%, the RSI 9-day stood at 33.38% on 22 June.
With respect to its five-day moving average, the current Tenet Healthcare Corporation price is up by +1.65% percent or $0.88. At present, THC shares trade -15.96% below its 20-day simple moving average and -25.83% percent below its 100-day simple moving average. However, the stock is currently trading approximately -35.48% below its SMA50 and -28.48% below its SMA200.
Stochastic coefficient K was 14.75% and Stochastic coefficient D was 13.26%, while ATR was 3.19. Given the Stochastic reading of 20.92% for the 14-day period, the RSI (14) reading has been calculated as 33.82%. As of today, the MACD Oscillator reading stands at -3.01, while the 14-day reading stands at -6.92.
Loop Capital launched its rating on Tenet Healthcare Corporation (NYSE: THC) to a Buy in a note to investors on June 17, 2022. Tenet Healthcare Corporation (THC) has been rated Buy by analysts. According to 0 brokerage firms, THC is a sell, and 3 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 2 analysts rate Tenet Healthcare Corporation stock as buy, with 15 recommending it as overweight.
With a median target price of $104.00, the current consensus forecast for the stock is $80.00 – $125.00. Based on these forecasts, analysts predict Tenet Healthcare Corporation (THC) will achieve an average price target of $102.67.